Companies: 10,795·Total market cap: $144.5T
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMYNYSEHealthcare● Active
$57.35
+$0.08(+0.13%)
Market Cap$117.1B
P/E Ratio—
52W High$62.89
52W Low$42.52
Cash on HandFinancialsRevenue

Bristol-Myers Squibb Company (BMY) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BMY · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$10.67B▼ -1.7% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$10.21B
cashAndCashEquivalents
Short-Term Investments
$464.0M
shortTermInvestments
YoY Change vs Prior Year
-1.7%
vs prior fiscal year
Latest Quarter
$10.49B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$10.67BCash on Hand
Total Debt$47.14BTotal Debt
Net Cash / Net Debt−$36.47BNet Debt Position
Cash vs Debt Ratio
Cash 18%Debt 82%

Bristol-Myers Squibb Company carries a net debt position of $36.47B. Total debt ($47.14B) exceeds cash on hand ($10.67B). Bristol-Myers Squibb Company cash vs debt ratio: 18% cash / 82% debt.

Net Cash = Cash & ST Investments − Total Debt$10.67B − $47.14B = −$36.47B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BMY annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$10.67B-1.7%
Dec 31, 2024$10.86B-11.6%
Dec 31, 2023$12.28B+32.7%
Dec 31, 2022$9.25B-46.3%
Dec 31, 2021$17.22B+4.7%
BMY cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Bristol-Myers Squibb Company
Bristol-Myers Squibb CompanyYOU
BMY
$10.67B9.2%
#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Bristol-Myers Squibb Company (BMY) cash on hand as of December 31, 2025 is $10.67B, comprising $10.21B in cash and cash equivalents (CCE) plus $464.0M in short-term investments — reported as Bristol-Myers Squibb Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bristol-Myers Squibb Company cash reserves or cash position.

Bristol-Myers Squibb Company annual cash on hand history shows decreased -1.7% in 2025: decreased -1.7% in 2025. Bristol-Myers Squibb Company cash reserves in 2025 reflect the company's capital allocation strategy.

Bristol-Myers Squibb Company carries total debt of $47.14B against cash of $10.67B, resulting in a net debt position of -$36.47B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

BMY cash on hand · 5 questions

As of December 31, 2025, Bristol-Myers Squibb Company (BMY) has $10.67B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $10.21B in cash and cash equivalents (CCE) plus $464,000,000 in short-term investments. Latest quarter (March 31, 2026): $10.49B. Data sourced from the annual 10-K filing via FMP.

BMY cash on handBMY cash reservesBMY cash 2025how much cash does BMY have

▸ Source: FMP /balance-sheet-statement · US GAAP · Bristol-Myers Squibb Company · Bristol-Myers Squibb Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025